Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

New class of TNF-alpha inhibitors safe and well tolerated in phase I

Nov. 12, 1997

rhIL-1ra provides long-term improvement in RA

Nov. 11, 1997

Clinical results reported for leflunomide in refractory RA and Wegener's granulomatosis

Nov. 11, 1997

Humanized anti-CD4 MAb suppresses synovial inflammation/cytokine levels

Nov. 11, 1997

MK-966 assessed in large trial in osteoarthritis of the knee and hip

Nov. 11, 1997

TNF/PDE inhibitors disclosed by Rhone-Poulenc Rorer

Nov. 6, 1997

MMP inhibitors reported by ProScript

Nov. 5, 1997

Peptides for autoimmune/inflammatory diseases linked to MHC molecules

Nov. 5, 1997

Mechanism of glucocorticoid antiinflammatory effects elucidated

Oct. 31, 1997

New immunomodulators for treating rheumatoid arthritis

Oct. 31, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 28, 2025
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...
OS Therapies heading to FDA with positive osteosarcoma data
BioWorld
With positive data in hand from its phase IIb trial testing immunotherapy candidate OST-HER2 in osteosarcoma, OS Therapies Inc. anticipates a regulatory filing...
Vilastobart set apart? Xilio phase II combo performs in CRC
BioWorld
“The [colorectal cancer field is moving, and thankfully it’s moving quickly,” said Marwan Fakih, gastrointestinal specialist at City of Hope, speaking about...